Sanofi
Selection marker for cell transfection and protein production
Last updated:
Abstract:
The present invention is within the field of industrial protein production. The invention provides a novel expression system using dehydroorotate dehydrogenase (DHODH) as a selection marker in combination with leflunomide or a metabolite thereof, notably for use in mammalian cell lines. Expression vectors encoding DHODH, cell lines comprising said vectors and methods of producing recombinant proteins are also provided.
Status:
Grant
Type:
Utility
Filling date:
26 Dec 2019
Issue date:
12 Jul 2022